A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody

Citation
Sb. Jiang et al., A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody, J VIROL MET, 80(1), 1999, pp. 85-96
Citations number
36
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF VIROLOGICAL METHODS
ISSN journal
01660934 → ACNP
Volume
80
Issue
1
Year of publication
1999
Pages
85 - 96
Database
ISI
SICI code
0166-0934(199906)80:1<85:ASAFAC>2.0.ZU;2-3
Abstract
The human immunodeficiency virus type 1 (HIV-1) gp41 plays an important rol e in membrane fusion between viruses and target cells. The gp41 ectodomain contains two heptad repeat regions adjacent to the N and C-termini. Peptide s derived from these two regions, designated N and C-peptides, are potent i nhibitors of HIV-1 infection and can interact with each other to form a six -stranded coiled-coil, representing the fusogenic core structure of gp41. A monoclonal antibody was generated, designated NC-1, which specifically bin ds to the complex formed by the N and C-peptides, but not to the individual peptides. An enzyme linked immunosorbent assay (ELISA) was developed using NC-1 for detecting complex formed by N and C-peptides and for screening of organic compounds for antiviral agents that may interfere with complex for mation and inhibit HIV-1 infection. Single point mutations in the C-peptide s abolish the complex formation also eliminate their anti-HIV-1 activity. A phenylazo-naphthalene sulfonic acid derivative, designated ADS-J1, was fou nd to inhibit both formation of NC-1 detectable complex and HIV-1-mediated membrane fusion, suggesting that the described ELISA is applicable to rapid screening of libraries of organic compounds for HIV-1 inhibitors targeted to the HIV-1 gp41 core structure. (C) 1999 Elsevier Science B.V. All rights reserved.